Medchem : Receptors, Drug Action and SAR. Final
53 Questions
2 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to Lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

How does long-term exposure to a drug that acts as an agonist typically affect postsynaptic receptors?

  • It can lead to receptor internalization or recycling, depending on neurotransmitter levels. (correct)
  • It consistently increases the number of receptors available on the postsynaptic membrane.
  • It has no significant impact on the number or sensitivity of postsynaptic receptors.
  • It directly increases neurotransmitter synthesis within the presynaptic neuron.

What primary role do autoreceptors play in regulating synaptic activity?

  • Inhibiting neurotransmitter release and modulating cyclic AMP, calcium, and potassium levels. (correct)
  • Directly activating postsynaptic receptors to propagate the signal.
  • Increasing the synthesis of neurotransmitters within the presynaptic neuron.
  • Enhancing the release of neurotransmitters into the synaptic cleft.

How do allosteric modulators influence the action of agonists at a receptor?

  • By competing with agonists for occupancy at the primary binding site.
  • By directly altering gene expression to change the number of receptors produced.
  • By binding to a separate site on the receptor, which affects the receptor's interaction with the agonist. (correct)
  • By independently causing full activation or complete inhibition of the receptor.

What distinguishes drug specificity from drug selectivity?

<p>Specificity implies direct binding and activity changes at one receptor, while selectivity indicates a drug binds one receptor more strongly or with higher activity compared to others. (A)</p> Signup and view all the answers

Which scenario exemplifies a drug exhibiting specificity for one receptor yet demonstrating non-selectivity?

<p>A drug binding to the CXCR6 receptor and causing activity there but also causing activity at CCR7 because CXCR6 dimerizes with CCR7. (C)</p> Signup and view all the answers

How is Structure-Activity Relationship (SAR) best defined in the context of drug discovery?

<p>The analysis to understand the quantitative relationship between variations in a drug's chemical structure and its biological activity. (C)</p> Signup and view all the answers

What crucial role does the pharmacophore play in SAR studies?

<p>Identifying and arranging the atoms and groups responsible for a biological molecule's specific biological activity. (A)</p> Signup and view all the answers

In SAR studies, what does the medicinal chemistry technique of 'truncation' aim to achieve?

<p>To identify the minimum structural features required for drug activity. (D)</p> Signup and view all the answers

A researcher is studying a new drug that shows high efficacy at a specific receptor but also binds to several other receptors with lower affinity. Which of the following terms best describes this drug's behavior?

<p>Selective (D)</p> Signup and view all the answers

A medicinal chemist is trying to optimize a lead compound. They remove a large, flexible substituent from the molecule, resulting in a significant loss of activity. What might be the most likely explanation for this observation?

<p>The substituent was crucial for binding to the receptor. (A)</p> Signup and view all the answers

A drug binds to a receptor, but the resulting complex doesn't trigger the expected cellular response. In SAR terms, which aspect of the drug's relationship to the receptor is most likely deficient?

<p>Efficacy (B)</p> Signup and view all the answers

A non-competitive antagonist impacts an agonist's activity in what way?

<p>A decrease in Emax and no change in EC50. (C)</p> Signup and view all the answers

Why is antagonism caused by a non-competitive antagonist considered insurmountable?

<p>Insurmountable, because the agonist cannot achieve Emax, no matter the concentration (D)</p> Signup and view all the answers

What statement differentiates full agonists, partial agonists, and antagonists?

<p>Full agonists elicit a maximal response (Emax = Bmax), partial agonists elicit a less than maximal response (Emax &lt; Bmax), and antagonists block the ability of an agonist to activate the receptor (no response) (B)</p> Signup and view all the answers

How would you best describe an inverse agonist?

<p>A drug that binds to the inactive receptor state and negatively activates the effector, resulting in a negative Emax. (D)</p> Signup and view all the answers

What are the intrinsic activity (alpha) values for a full agonist, partial agonist, antagonist, and inverse agonist?

<p>1, between 0 and 1, 0, between 0 and -1 (D)</p> Signup and view all the answers

How does the presence of a partial agonist affect the Emax of a full agonist when both bind to the same receptor?

<p>The partial agonist will lower the overall response because it occupies receptor sites without fully activating them, thus decreasing the Emax of the full agonist. (D)</p> Signup and view all the answers

Which of the following best defines pharmacokinetics (PK)?

<p>What the body does to the drug as it moves through the body, including absorption, distribution, metabolism, and excretion (ADME). (D)</p> Signup and view all the answers

How can the absorption process influence a drug's pharmacodynamic effects?

<p>By affecting how much of the drug enters the bloodstream, thus impacting free drug concentration. (C)</p> Signup and view all the answers

A patient's liver function can significantly impact drug concentrations and effects by influencing which PK process?

<p>Metabolism (B)</p> Signup and view all the answers

How does pharmacogenomics contribute to variability in drug response?

<p>By studying how genes affect a person's response to a drug, impacting pharmacokinetics, pharmacodynamics, and toxicology. (A)</p> Signup and view all the answers

Drug-receptor interactions can initiate intracellular signaling cascades by:

<p>Binding to receptors on cells, initiating communication and signaling from outside the cell to inside the cell. (A)</p> Signup and view all the answers

Prolonged exposure to a drug can lead to compensatory mechanisms and tolerance, where the body:

<p>Adapts to normalize the signal by changing synthesis, storage, release, receptor binding, and metabolism. (C)</p> Signup and view all the answers

How does neurotransmitter binding affect receptor number?

<p>Leads to endocytosis and receptor degradation. (B)</p> Signup and view all the answers

Two drugs produce the same maximal effect but have different EC50 values. Drug X has an EC50 of 5 nM, while Drug Y has an EC50 of 500 nM. Which drug is more potent?

<p>Drug X, because it requires a lower concentration to achieve 50% of the maximal effect. (A)</p> Signup and view all the answers

Which of the following options best describes the relationship between Kon, Koff, and drug residence time?

<p>Drug residence time is inversely proportional to Koff and is calculated as 1/Koff. (D)</p> Signup and view all the answers

What is the formula for calculating drug residence time?

<p>Residence Time = 1 / Koff (D)</p> Signup and view all the answers

If the Koff rate decreases while the Kd (dissociation constant) remains constant, what must happen to the Kon rate?

<p>The Kon rate must decrease. (D)</p> Signup and view all the answers

Which of the following is an advantage of a drug with fast receptor kinetics (rapid Kon and Koff)?

<p>Quick onset and offset of action, useful for acute conditions. (D)</p> Signup and view all the answers

In which therapeutic area would a drug with slow receptor kinetics (slow Kon and Koff) be most advantageous?

<p>Long-term anxiety control. (A)</p> Signup and view all the answers

Which of the following is a key assumption of the Law of Mass Action in drug-receptor interactions?

<p>One drug molecule binds to one receptor molecule reversibly. (A)</p> Signup and view all the answers

How do spare receptors affect the relationship between receptor occupancy and drug response?

<p>They allow a maximal response (Emax) to be achieved without occupying all available receptors. (C)</p> Signup and view all the answers

In the presence of spare receptors, how does the EC50 relate to the Kd?

<p>EC50 is lower than Kd (D)</p> Signup and view all the answers

In the presence of a competitive antagonist, what change will occur to the agonist dose-response curve?

<p>No change in Emax and a shift of the curve to the right, indicating an increase in EC50. (C)</p> Signup and view all the answers

Is the antagonism caused by a competitive antagonist surmountable or insurmountable?

<p>Surmountable, because the agonist can still achieve Emax at higher concentrations (A)</p> Signup and view all the answers

Choose the statement that best describes insurmountable antagonism:

<p>The maximal response to the agonist is reduced, regardless of the concentration of the agonist. (D)</p> Signup and view all the answers

If a drug has a high Kon and a low Koff, what does this indicate about its receptor binding?

<p>Fast association and slow dissociation, leading to long receptor occupancy. (D)</p> Signup and view all the answers

How is drug potency affected by the presence of spare receptors??

<p>Potency is increased, requiring lower concentrations of the drug for the same effect. (C)</p> Signup and view all the answers

What is the primary function of the pharmacophore in drug design?

<p>To identify the chemical functional groups on a molecule that interact with the target, causing positive interactions. (B)</p> Signup and view all the answers

How does 'truncation' in SAR (Structure-Activity Relationship) studies aid in identifying the pharmacophore?

<p>By systematically removing and replacing chemical groups with a hydrogen to determine the minimum structural features necessary for activity. (B)</p> Signup and view all the answers

Which statement accurately defines the Therapeutic Index (TI)?

<p>The ratio of the TD50 (toxic dose in 50% of the population) to the ED50 (effective dose in 50% of the population). (D)</p> Signup and view all the answers

What does a high Therapeutic Index (TI) suggest about a drug's safety profile?

<p>The drug is relatively safe, as there is a large separation between the dose required for therapeutic effect and the dose that causes toxicity. (A)</p> Signup and view all the answers

Which of the following accurately describes the Certain Safety Factor (CSF)?

<p>The ratio of the toxic dose in 1% of the population to the effective dose in 99% of the population. (C)</p> Signup and view all the answers

Which formula is correctly used to calculate the Certain Safety Factor (CSF)?

<p>CSF = Toxic Dose (1%) / Effective Dose (99%) (B)</p> Signup and view all the answers

Under which circumstance is the Certain Safety Factor (CSF) a more pertinent measurement than the Therapeutic Index (TI) for safety assessment?

<p>When the drug response does not follow the law of mass action. (A)</p> Signup and view all the answers

What does it signify when a drug is described as having a narrow therapeutic window?

<p>There is a small difference between the effective dose and the toxic dose, increasing the risk of adverse effects. (C)</p> Signup and view all the answers

How does a narrow therapeutic window influence the dosage and monitoring of a patient taking the drug?

<p>Dosing must be carefully controlled, and the patient should be closely monitored for signs of toxicity. (A)</p> Signup and view all the answers

What is indicated by a drug that has a wide therapeutic window?

<p>The drug is relatively safe, allowing for a broader range of doses without significant risk of toxicity, simplifying dosing and monitoring (A)</p> Signup and view all the answers

Which of the following statements provides the MOST accurate definition of Emax?

<p>The maximal response that a drug can produce, regardless of the concentration. (A)</p> Signup and view all the answers

Which statement best describes EC50?

<p>The drug concentration that produces 50% of the maximal effect. (A)</p> Signup and view all the answers

How do you define drug potency in pharmacology?

<p>The amount of drug required to produce a particular effect. (C)</p> Signup and view all the answers

What is the significance of drug efficacy in pharmacology?

<p>The maximal effect a drug can produce. (A)</p> Signup and view all the answers

Which of the following best describes drug affinity?

<p>A measure of how tightly a drug binds to its receptor. (C)</p> Signup and view all the answers

Flashcards

Drug Specificity

A drug directly causes activity changes at one specific receptor.

Drug Selectivity

A drug binds one receptor more strongly than others, causing activity changes.

Example of Specific but Non-Selective Drug

Drug binds to CXCR6 receptor and causes activity there but also causes activity at CCR7 because CXCR6 dimerizes with CCR7.

Structure-Activity Relationship (SAR)

Analysis to understand the relationship between chemical structure and biological activity.

Signup and view all the flashcards

Pharmacophore

The set of structural features in a molecule that is recognized at a receptor site and is responsible for its biological activity.

Signup and view all the flashcards

Role of Pharmacophore

The pharmacophore defines how the atoms of the drug interact with the receptor on a molecular level

Signup and view all the flashcards

Truncation in SAR studies

Removing parts of a molecule to find the smallest structure still needed for activity.

Signup and view all the flashcards

Why Use Truncation?

Medicinal chemists use truncation to reveal the core structural elements required for biological activity.

Signup and view all the flashcards

Receptor Regulation

Receptor regulation can increase or decrease receptor numbers in response to neurotransmitter levels.

Signup and view all the flashcards

Autoreceptor Function

Autoreceptors inhibit neurotransmitter release & modulate cAMP, calcium, & potassium levels.

Signup and view all the flashcards

Allosteric Modulator Action

Allosteric modulators bind a different receptor site and alter the receptor's interaction with the agonist; they don't compete directly.

Signup and view all the flashcards

Endocytosis Definition

Endocytosis involves vesicular transport into a cell.

Signup and view all the flashcards

Receptor Vesicular Transport

Receptors are transported into and out of the cell through vesicular transport.

Signup and view all the flashcards

Therapeutic Index (TI)

The ratio of the TD50 (toxic dose in 50% of the population) to the ED50 (effective dose in 50% of the population).

Signup and view all the flashcards

High Therapeutic Index

A high TI indicates a large separation between effective and toxic doses; relatively safe.

Signup and view all the flashcards

Certain Safety Factor (CSF)

The ratio of the toxic dose in 1% of the population to the effective dose in 99% of the population.

Signup and view all the flashcards

CSF Formula

CSF = Toxic Dose (1%) / Effective Dose (99%).

Signup and view all the flashcards

When to use CSF over TI?

When the drug response does not follow the law of mass action.

Signup and view all the flashcards

Narrow Therapeutic Window (NTW)

A small difference between the effective dose and the toxic dose, increasing the risk of adverse effects.

Signup and view all the flashcards

NTW Implications: Dosing & Monitoring

Dosing must be carefully controlled, and the patient should be closely monitored for signs of toxicity.

Signup and view all the flashcards

Wide Therapeutic Window (WTW)

The drug is relatively safe, allowing for a broader range of doses without significant risk of toxicity, simplifying dosing and monitoring

Signup and view all the flashcards

Emax

The maximal response that a drug can produce, regardless of the concentration.

Signup and view all the flashcards

EC50

The drug concentration that produces half of the maximal response; it measures drug potency.

Signup and view all the flashcards

SAR Studies

Measure to determine what part of the drug molecule is responsible for interacting with the target to cause the positive interactions.

Signup and view all the flashcards

Drug Adverse Effects at low doses

The drug is likely to cause significant side effects, even at low doses.

Signup and view all the flashcards

Drug can be very safe at low doeses

Drug has great therapeutic potentcy.

Signup and view all the flashcards

More Potent Drug (Lower EC50)

The drug that requires a lower concentration to produce 50% of the maximal effect.

Signup and view all the flashcards

Kon, Koff, and Residence Time

Association rate (Kon), dissociation rate (Koff) and drug residence time are related to how long a drug stays bound to its target.

Signup and view all the flashcards

Drug Residence Time Formula

Drug residence time equals 1 divided by the dissociation rate (Koff).

Signup and view all the flashcards

Koff and Kon Rate Relationship

If Kd is constant, an increase in Koff requires an increased Kon to maintain equilibrium.

Signup and view all the flashcards

Advantage of Fast Receptor Kinetics

A fast Kon and Koff is useful for acute conditions needing quick onset and offset.

Signup and view all the flashcards

Advantage of Slow Receptor Kinetics

Slow receptor kinetics are most useful for conditions needing long-term, sustained effects.

Signup and view all the flashcards

Law of Mass Action Key Assumption

One drug molecule binds reversibly to one receptor molecule.

Signup and view all the flashcards

Effect of Spare Receptors

Spare receptors allow maximal response without full receptor occupancy.

Signup and view all the flashcards

EC50 vs. Kd with Spare Receptors

EC50 is lower than Kd because spare receptors amplify signaling.

Signup and view all the flashcards

Competitive Antagonist – Curve Change

A competitive antagonist shifts the agonist dose-response curve to the right (increases EC50) without changing Emax.

Signup and view all the flashcards

Competitive Antagonism - Surmountable

The agonism is surmountable because higher agonist concentrations can still achieve Emax.

Signup and view all the flashcards

Non-Competitive Antagonist – Curve Change

A non-competitive antagonist reduces the maximal response (Emax).

Signup and view all the flashcards

Non-Competitive Emax EC50

Emax decreases, EC50 may not change predictably but it's irrelevant because Emax

Signup and view all the flashcards

Non-Competitive Antagonism - Insurmountable

It is insurmountable because the antagonist binds irreversibly or at a different site, so increasing agonist cannot restore Emax.

Signup and view all the flashcards

Full Agonist

Binds to a receptor, produces maximal response (Emax = Bmax).

Signup and view all the flashcards

Partial Agonist

Binds to a receptor, produces a submaximal response (Emax < Bmax).

Signup and view all the flashcards

Antagonist

Blocks the ability of an agonist to activate the receptor (no response).

Signup and view all the flashcards

Inverse Agonist

Binds to the inactive receptor state which negatively activates the effector, resulting in a negative Emax.

Signup and view all the flashcards

Intrinsic Activity (alpha) Values

Full agonist: 1, partial agonist: between 0 and 1, antagonist: 0, inverse agonist: between 0 and -1.

Signup and view all the flashcards

Partial Agonist Effect on Full Agonist Emax

The partial agonist will lower the overall response because it occupies receptor sites without fully activating them, thus decreasing the Emax of the full agonist.

Signup and view all the flashcards

Pharmacokinetics (PK)

What the body does to the drug as it moves through the body, including absorption, distribution, metabolism, and excretion (ADME).

Signup and view all the flashcards

Absorption Influence on Pharmacodynamics

By affecting how much of the drug enters the bloodstream, thus impacting free drug concentration.

Signup and view all the flashcards

Liver Function Impact on PK

Metabolism.

Signup and view all the flashcards

Pharmacogenomics Contribution

By studying how genes affect a person's response to a drug, impacting pharmacokinetics, pharmacodynamics, and toxicology.

Signup and view all the flashcards

Drug-Receptor Interaction Initiation

Binding to receptors on cells, initiating communication and signaling from outside the cell to inside the cell.

Signup and view all the flashcards

Compensatory Mechanisms and Tolerance

Adapts to normalize the signal by changing synthesis, storage, release, receptor binding, and metabolism.

Signup and view all the flashcards

Effect of a Non-Competitive Antagonist

A decrease in Emax and no change in EC50

Signup and view all the flashcards

Antagonism Caused by Non-Competitive Antagonist

Insurmountable, because the agonist cannot achieve Emax, no matter the concentration

Signup and view all the flashcards

Differentiate Between Full Agonists, Partial Agonists, and Antagonists

Full agonists elicit a maximal response (Emax = Bmax), partial agonists elicit a less than maximal response (Emax < Bmax), and antagonists block the ability of an agonist to activate the receptor (no response)

Signup and view all the flashcards

Study Notes

Fundamental Concepts & Terminology

  • Specificity refers to a drug's ability to bind directly and cause activity changes at one receptor.
  • Selectivity refers to a drug's ability to bind one receptor more strongly or with higher activity compared to others.
  • A drug that binds to the CXCR6 receptor and causes activity there but also causes activity at CCR7 has specificity for one receptor but is non-selective. This can occur because CXCR6 dimerizes with CCR7.
  • Structure-Activity Relationship (SAR) involves analyzing the relationship between a drug's chemical structure and its biological activity.
  • The pharmacophore in SAR studies identifies the chemical functional groups on a molecule that interact with the target, causing positive interactions.
  • Medicinal chemists use "truncation" in SAR studies by systematically removing and replacing chemical groups with a hydrogen to determine the minimum structural features necessary for activity.
  • Therapeutic Index (TI) defines the ratio of the TD50 (toxic dose in 50% of the population) to the ED50 (effective dose in 50% of the population).
  • A high Therapeutic Index (TI) indicates a drug is relatively safe, as there is a large separation between the dose required for therapeutic effect and the dose that causes toxicity.
  • Certain Safety Factor (CSF) defines the ratio of the toxic dose in 1% of the population to the effective dose in 99% of the population.
  • The formula for calculating the Certain Safety Factor (CSF) is: CSF = Toxic Dose (1%) / Effective Dose (99%).
  • The Certain Safety Factor (CSF) provides a more relevant safety assessment compared to the Therapeutic Index (TI) when the drug response doesn't follow the law of mass action.
  • A narrow therapeutic window signifies that there is a small difference between the effective dose and the toxic dose, which increases the risk of adverse effects.
  • When a drug has a narrow therapeutic window, dosing must be carefully controlled, and the patient should be closely monitored for signs of toxicity.
  • A wide therapeutic window signifies that the drug is relatively safe, allowing for a broader range of doses without significant risk of toxicity, simplifying dosing and monitoring.

Pharmacodynamics (PD) - Drug-Receptor Interactions

  • Emax is the maximal response that a drug can produce, regardless of the concentration.
  • EC50 defines the drug concentration that produces 50% of the maximal effect.
  • If two drugs, A and B, produce the same maximal effect (Emax) but have different EC50 values, drug A is more potent if has a lower EC50 (Drug values: Drug A (EC50:10 nM), Drug B (EC50: 100 nM)).
  • Drug residence time is inversely proportional to Koff and is calculated as 1/Koff.
  • If the Koff rate increases while the Kd remains constant, the Kon rate must increase.
  • A drug with fast receptor kinetics (rapid Kon and Koff) has quick onset and offset of action, making it useful for acute conditions.
  • A drug with slow receptor kinetics (slow Kon and Koff) is more advantageous for long-term conditions like anxiety control.
  • The Law of Mass Action states that one drug molecule binds to one receptor molecule reversibly.
  • Spare receptors allow a maximal response (Emax) to be achieved without occupying all available receptors.
  • In the presence of spare receptors, the EC50 is lower than the Kd.
  • In the presence of a competitive antagonist, the agonist dose-response curve shows no change in Emax and a shift of the curve to the right, indicating an increase in EC50.
  • The antagonism caused by a competitive antagonist is surmountable because the agonist can still achieve Emax at higher concentrations.
  • In the presence of a non-competitive antagonist, the agonist dose-response curve shows a decrease in Emax and no change in EC50.
  • The antagonism caused by a non-competitive antagonist is insurmountable because the agonist cannot achieve Emax, no matter the concentration.

Comparing Modes of Action

  • Full agonists elicit a maximal response (Emax = Bmax).
  • Partial agonists elicit a less than maximal response (Emax < Bmax).
  • Antagonists block the ability of an agonist to activate the receptor (eliciting no response).
  • Inverse Agonist bind to the inactive receptor state and negatively activates the effector, resulting in a negative Emax.
  • Intrinsic activity (alpha) values for a full agonist, partial agonist, antagonist, and inverse agonist are: 1, between 0 and 1, 0, between 0 and -1, respectively
  • When a full agonist and a partial agonist both bind to the same receptor, the partial agonist will lower the overall response because it occupies receptor sites without fully activating them.
  • The partial agonist will decrease the Emax of the full agonist.

Pharmacokinetics/Pharmacodynamics (PK/PD) Integration

  • Pharmacokinetics (PK) is defined as what the body does to the drug, what the body does to the drug as it moves through the body, including absorption, distribution, metabolism, and excretion (ADME).
  • The absorption process can influence a drug's pharmacodynamic effects by affecting how much of the drug enters the bloodstream, thus impacting free drug concentration.
  • A patient's liver function can significantly impact drug concentrations and effects by influencing the metabolism process.
  • Pharmacogenomics contributes to variability in drug response by studying how genes affect a person's response to a drug, impacting pharmacokinetics, pharmacodynamics, and toxicology.

Signaling and Compensatory Actions

  • Drug-receptor interactions can initiate intracellular signaling cascades by binding to receptors on cells, initiating communication and signaling from outside the cell to inside the cell.
  • Prolonged exposure to a drug can lead to compensatory mechanisms and tolerance, where the body adapts to normalize the signal by changing synthesis, storage, release, receptor binding, and metabolism.
  • Neurotransmitter binding can lead to receptor internalization (decreasing receptor numbers) or receptor recycling (increasing receptor numbers), depending on neurotransmitter levels.
  • Autoreceptors regulate neurotransmitter release and synaptic activity by inhibiting neurotransmitter release and modulating cyclic AMP, calcium, and potassium levels.
  • Allosteric modulators affect the action of agonists by binding to a different site on the receptor and altering the receptor's interaction with the agonist.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

Explores the impact of long-term drug exposure on postsynaptic receptors, the role of autoreceptors, and allosteric modulation. Also covers drug specificity versus selectivity, SAR, pharmacophore importance, and truncation.

More Like This

Intro to Drug Action (tbc)
34 questions
Principles of Drug Action Quiz
30 questions
Pharmacology: Drug Action Mechanisms
26 questions
Pharmacology: Drug Actions and Receptors
40 questions
Use Quizgecko on...
Browser
Browser